|
|
|
Insider
Information: |
Karsen Perry A |
Relationship: |
Director |
City: |
Rockville |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
272,994 |
|
Indirect Shares
|
1,639 |
|
|
Direct
Value |
$10,381,810 |
|
|
Indirect Value
|
$177,405 |
|
|
Total
Shares |
274,633 |
|
|
Total
Value |
$10,559,215 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-35.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celgene Corp |
CELG |
see remarks |
2015-12-17 |
66,432 |
2015-12-17 |
1,639 |
Premium* |
|
Navidea Biopharmaceuticals |
NAVB |
Director |
2015-07-16 |
37,528 |
2014-02-17 |
0 |
Premium* |
|
Jounce Therapeutics Inc |
JNCE |
Director |
2023-05-03 |
0 |
2017-02-01 |
0 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2020-12-17 |
5,000 |
2017-06-01 |
0 |
Premium* |
|
Lenz Therapeutics |
LENZ |
Director |
2021-06-29 |
164,034 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CELG |
Celgene Corp |
see remarks |
|
2013-05-13 |
4 |
AS |
$115.00 |
$5,424,895 |
D/D |
(47,173) |
62,820 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2013-08-02 |
4 |
OE |
$0.00 |
$5,312,410 |
D/D |
118,008 |
118,464 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2013-08-02 |
4 |
D |
$147.35 |
$1,909,951 |
D/D |
(12,962) |
105,502 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2013-08-02 |
4 |
S |
$146.50 |
$13,625,672 |
D/D |
(93,008) |
12,494 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2013-11-01 |
4 |
D |
$151.31 |
$784,516 |
D/D |
(5,185) |
17,309 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2013-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
22,494 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2013-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,777 |
25,086 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2013-12-27 |
4 |
D |
$168.93 |
$681,126 |
D/D |
(4,032) |
21,054 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,188 |
36,242 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-02-12 |
4 |
D |
$160.54 |
$1,264,092 |
D/D |
(7,874) |
28,368 |
0 |
- |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2014-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-03-03 |
4 |
AS |
$159.05 |
$382,992 |
D/D |
(2,408) |
25,960 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-05-01 |
4 |
OE |
$59.50 |
$694,187 |
D/D |
11,667 |
37,627 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-05-01 |
4 |
AS |
$146.78 |
$1,749,911 |
D/D |
(11,922) |
25,705 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-08-04 |
4 |
OE |
$28.16 |
$1,308,032 |
D/D |
46,450 |
97,860 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-08-04 |
4 |
AS |
$87.55 |
$3,423,434 |
D/D |
(39,104) |
58,756 |
0 |
- |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2014-11-10 |
4 |
A |
$1.32 |
$13,533 |
D/D |
10,252 |
30,252 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-11-12 |
4 |
AS |
$107.23 |
$4,227,007 |
D/D |
(39,420) |
51,410 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-11-12 |
4 |
OE |
$25.77 |
$1,055,391 |
D/D |
32,074 |
90,830 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-12-30 |
4 |
OE |
$29.75 |
$694,187 |
D/D |
23,334 |
74,744 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-12-30 |
4 |
AS |
$113.37 |
$2,184,980 |
D/D |
(19,273) |
55,471 |
0 |
- |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2015-02-05 |
4 |
A |
$1.89 |
$13,752 |
D/D |
7,276 |
37,528 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-02-06 |
4 |
D |
$118.75 |
$1,871,263 |
D/D |
(15,758) |
70,117 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,404 |
85,875 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-02-11 |
4 |
OE |
$34.70 |
$1,046,520 |
D/D |
27,896 |
98,013 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|